Petersburg City Public Schools announced the opening of a new playground at Pleasants Lane Elementary School in Petersburg, Virginia.
Press Releases
National Essential Medicine Shortage Awareness Day Highlights a Critical Public Health Issue that Demands America’s Attention
Phlow announces its support of the first annual National Essential Medicine Shortage Awareness Day. This observance was created to educate the public about the ongoing crisis of essential medicine shortages in the United States.
Phlow Corp. Receives The U.S Department of Health and Human Services, Office of Small and Disadvantaged Business Utilization, Small Business Prime Contractor of the Year Award
The U.S. Department of Health and Human Services (HHS), recently announced that Phlow Corp. has been awarded the Office of Small and Disadvantaged Business Utilization (OSDBU), Small Business Prime Contractor of the Year Award. Phlow Corp. is a U.S.-based, public benefit corporation committed to solving America’s broken essential medicine supply chain. This award recognizes Phlow for its performance during the previous fiscal year on its contract with HHS.
Phlow Corporation Supports Biden Administration Efforts to Strengthen the Pharmaceutical Supply Chain
The pieces of a Petersburg pharmaceuticals hub continue to fall into place.
Leading Children’s Hospitals and Phlow Corp. Form an Unprecedented Coalition to Deliver Essential Medicines to Address Pediatric Drug Shortages
RICHMOND, Va., March 18, 2021 – Phlow Corp., a U.S.-based, public benefit corporation committed to a bold mission of providing every American with access to affordable, high-quality essential medicines, today joins in announcing the launch of a groundbreaking...
Phlow Corp. and USP Announce Strategic Alliance Focused on Pharmaceutical Continuous Manufacturing to Increase Supply of Essential Medicines for U.S. Patients
Phlow and the United States Pharmacopeia have formed a strategic alliance to develop a new laboratory that will certify and validate Pharmaceutical Continuous Manufacturing processes resulting in affordable, high-quality, U.S.-manufactured essential medicines.
Phlow Corp. Closes $20 Million Series A Financing to Further Essential Medicines Research and Development Programs and Advanced Manufacturing Initiatives
This injection of additional strategic capital will further enhance Phlow’s mission to reimagine the end-to-end domestic production critical to U.S. healthcare.
New Pharma Company Lands $354 Million Government Contract to Produce Coronavirus Drugs in the U.S.
Move Strengthens America’s Supply Chain and Supports COVID-19 Response.